AN2 Therapeutics, Inc. - stock earnings
ANTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -16.7 million USD | ? USD |
| 2023Q2 | -15.8 million USD | ? USD |
| 2023Q1 | -14.6 million USD | ? USD |
| 2022Q4 | -12.8 million USD | ? USD |
| 2022Q3 | -10.9 million USD | ? USD |
| 2022Q2 | -9.7 million USD | ? USD |
| 2022Q1 | -7.6 million USD | ? USD |
| 2021Q4 | -7.5 million USD | ? USD |
| 2021Q3 | -6.9 million USD | ? USD |
| 2021Q2 | -5.0 million USD | ? USD |
| 2021Q1 | -2.0 million USD | ? USD |
ANTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -59.7 million USD | ? USD |
| 2022 | -41.5 million USD | ? USD |
| 2021 | -21.5 million USD | ? USD |
| 2020 | -13.6 million USD | ? USD |
| 2019 | -5.6 million USD | ? USD |
ANTX
Price: $2.56
52 week price:
Earnings Per Share: -2.80 USD
P/E Ratio: -7.50
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 47599
Market Capitalization: 90.7 million
Average Dividend Frequency: 3